Gossamer Bio USA, Inc.
2 clinical trials · Sponsor
◉ Watch Gossamer Bio USA, Inc.
| Record | Firm | Date |
|---|---|---|
| Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) (NCT06274801) | Gossamer Bio USA, Inc. | 2024-09-03 |
| Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) (NCT04816604) | Gossamer Bio USA, Inc. | 2021-04-05 |
Track Gossamer Bio USA, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.